SARRP Used on Intradermal Melanoma Tumor Model

September 1, 2021

Earlier this year, researchers identified a new intradermal melanoma model for melanoma immunotherapy combination studies, the Cloudman S91. The article, “Cloudman S91 – a responsive syngeneic melanoma model” by Sumithra Urs, PhD, Senior Scientist, Scientific Development,  Labcorp, described how SARRP was used to evaluate the tumor model’s sensitivity to radiation. The study found dose-dependent tumor regression from single radiation treatments.

Learn more below and view the original article here.

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts